Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: In a recently completed 3-year, randomized, double-blind study, denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κB ligand, significantly increased bone mineral density and decreased new vertebral fractures in men receiving androgen deprivation thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Matthew R., Saad, Fred, Egerdie, Blair, Szwedowski, Maciej, Tammela, Teuvo L. J., Ke, Chunlei, Leder, Benjamin Z., Goessl, Carsten
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900763/
https://ncbi.nlm.nih.gov/pubmed/19836774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados